Background: Cardiovascular diseases, including hypertension and type 2 diabetes mellitus, are the major determinants of poor health in the Russian Federation.
C ardiovascular disease (CVD), including hypertension and diabetes mellitus, are the major determinants of poor health in the Russian Federation. This disease spectrum is responsible for nearly 60% of deaths excluding trauma and violence, and contributes substantially to male longevity being less than 60 years. 1 The coexistence of hypertension and diabetes is a major problem for public health, in part because both are risk factors for coronary artery disease.
The most important goals of chronic disease management are to decrease mortality and morbidity, to prevent complications, and to enhance quality of life. These can be approached through a systematic program that includes patient identification, risk factor management, active therapy, and predictable and regular follow-up. Success in large part depends on physician/provider continuity and availability, and the predictability of the system.
Health care in the Russian Federation is a state run global system based in the polyclinic, a full service, outpatient facility available in all communities. 2 This system stresses active therapy for active problems, but does not have a substantive public health commitment to chronic disease management. Our group inaugurated a pilot project for hypertension surveillance and management in an urban polyclinic in residential Kazan, a city of 1.4 million people and the capital of the semiautonomous republic of Tatarstan, located on the Volga river 800 km southeast of Moscow.
The objective of our research was to establish within a polyclinic a hypertension identification and management program. Hypertension was viewed as a window onto the spectrum of CVD, including diabetes, and all enrolled patients were screened for CVD risk factors and diabetes, for which therapy and counseling would be available. It is estimated that 39% of Russian men and 41% of Russian women have hypertension, defined as blood pressure (BP) Ն140/90 mm Hg. The prevalence is higher in men up to age 40 years, but in people more than 50 years of age, the prevalence is higher in women. 3 Similar results were found in a phone survey of Moscow residents. 4 In Novosobirsk 30% of men and 27 % of women in the 35-to 64-year age group had a systolic BP Ն160 mm Hg or a diastolic BP Ն90 mm Hg.
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Methods
Kazan polyclinic #18 has 30 doctors and is responsible for the health care of 77, 000 people. We recruited adult patients by identifying hypertensive individuals at their regular polyclinic visits for any reason-common cold, asthma, gout-and by identifying patients with hypertension followed by the polyclinic. From March 2000 to July 2002 we enrolled 124 patients with hypertension uncomplicated by diabetes and 68 patients with hypertension and type 2 diabetes, all of whom agreed to participate in this long-term program. Approximately 35 patients, most of them men, declined several invitations to participate; they were not followed. Patients were assigned to general practitioners, called therapists in the polyclinic system. 2 Therapists are generalist physicians who have completed a 1-year clinical training program, usually in a nonacademic hospital, before beginning work in the polyclinic system. The staff had been informed about the project and had received 20 h of continuing medical education (CME) devoted to hypertension and risk factor modification before enrolling patients. The program was supported by the academic community and the Tatarstan Ministry of Health as well as consultants from the United States.
Patients were followed from 6 to 24 months with a mean of 18 months. Patients had on average six visits to the polyclinic. Patients who missed an appointment were contacted by the polyclinic staff, usually the therapists, to reschedule. At each visit the patients had their BP measured, underwent a brief physical examination, and were asked questions about their complaints and condition. At each visit patients were counseled on risk factor modification, specifically diet, exercise, smoking, and alcohol.
Because of the known high rate of noncompliance with risk factor modification, the physicians tried to identify patient characteristics that defined patterns of behavior. Using a schema designed by one of us (MRT), noncompliance was considered erratic if patients understood recommendations, accepted life style suggestions, but followed neither. This pattern was seen in middle-aged working men and in the elderly of both genders. Noncompliance was considered unwitting if patients thought they followed instructions but did not. This behavior was seen most frequently in elderly patients with limited education. Intentional noncompliance was characterized by cessation of therapy because of feeling better or perceiving no response to therapy. Younger patients with limited education most often displayed this behavior. These incidences are displayed in Table 1 . Although the numbers are small, these observations can serve as a hypothesis for future studies.
All of the patients were prescribed antihypertensive treatment according to international standard treatment guidelines. The Russian Federation guidelines are based on those developed by the World Health Organization (WHO)-International Society of Hypertension (ISH).
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The usual agents prescribed were angiotensin-converting enzyme (ACE) inhibitors, ␤-blockers, calcium channel blockers, imidazoline derivatives, and diuretics, Combination of drugs or increases in doses were prescribed at the discretion of the physician. The most commonly prescribed drugs in each class were enalapril ( Patients had blood and urine analyses and electrocardiograms twice a year. Echocardiograms were obtained at baseline and thereafter at the discretion of the physician. Patients with diabetes had fasting blood sugar (FBS) tests regularly and every 3 months they had glycosylated hemoglobin (HbA 1c ) measured. Antihyperglycemic therapy was prescribed by an endocrinologist. The goal was to achieve an HbA 1c Ͻ8.0%. Once a year patients were examined by an ophthalmologist.
Compliance with therapy and life style recommendations was assessed by conversations with patients that asked questions on diet, calorie consumption, smoking, and frequency and type of exercise. Pill counts were also used.
Results
Baseline characteristics are presented in Table 2 . One of the most striking observations is the low percentage of men (46/192; 25%) enrolled. This pattern, however, reflects the usage of the polyclinic system itself throughout the Russian Federation. These patients knew they had hypertension, but prior therapy was irregular, without predictable follow-up, and clearly not effective. The patients had quite advanced hypertensive disease, as well as complex metabolic derangements. Left ventricular hypertrophy was defined by the electrocardiographic criteria of Sokolow and Lyon 7 and 85% of patients in both groups met these criteria. Of these, 30% satisfied echocardiographic criteria of left ventricular hypertrophy, displaying Ն12-mm wall thickness in both the anterior septum and the posterior wall. More than 80% were obese and more than two-thirds had elevated cholesterol levels ( Table 2) .
There were several significant (P Ͻ .05) differences between men and women (Table 3) . Women with isolated hypertension were more likely to have a body mass index (BMI) Ͼ 25 kg/m 2 , elevated cholesterol, and a history of a prior cerebrovascular accident (CVA). In the group with both hypertension and diabetes, men were more likely to have had a prior MI and prior CVA. This group, however, was significantly older than the group with isolated hypertension. In this self-selected cohort none of the women and only 25% of the men smoked, whereas in the country as a whole, approximately 10% of women and 45 % of men between the ages of 35 to 64 years smoked. 8 In the younger age groups, the prevalence is higher. Abbreviations as in Table 2 .
Overall the response to therapy in this group of advanced hypertensive patients was modest, at best. Blood pressure in the hypertensive only group decreased from 173.9 Ϯ 20.6/104 Ϯ 15.3 mm Hg to 160.4 Ϯ 26.0/98.6 Ϯ 15.9 mm Hg (P Ͻ .05). In the group with both hypertension and diabetes the BP decreased from 177.9 Ϯ 26.0/ 97.9 Ϯ 16.4 mm Hg to 157.9 Ϯ 24.3/90.9 Ϯ 17.2 mm Hg (P Ͻ .05). However, in these groups only 26% of patients with hypertension alone and 32% of patients with both hypertension and diabetes reached high normal levels of 140/90 mm Hg.
During the course of the study, there was little change in cholesterol levels or prevalence of smoking in either group and in the diabetic group, there was little change in either FBS or HbA 1c levels.
We measured compliance in three arenas in this program. Compliance with medications was high, more than 90%. Compliance with follow-up visits was low, 11%, if patients were not reminded of their visit by the polyclinic staff. However, it was 93% if the physician called the patient to remind him or her of the visit. Compliance with life style or behavioral recommendations was poor as reflected by lack of weight loss, failure to increase exercise frequency, and unchanged risk factor markers ( Table 1) .
Discussion
There were three primary goals of this study. The first and most important was to determine whether the polyclinic staff could recruit, treat, and sustain ongoing management of patients with hypertension. In addition, would the role of preventive medicine be perceived within the culture of the polyclinic as acceptable.
The second goal was to determine whether the current practice model within the polyclinic was equipped with the tools to lower BP effectively and modify risk factors. These tools included clinical skills, comprehension of contemporary therapeutic end points, facility with pharmaceuticals, and monitoring and management skills. The third goal was to determine whether the current program led to a substantial improvement in the risk factor profile of enrolled patients.
The follow-up of enrolled patients exceeded expectations. All of the patients enrolled for 1 year or more completed the full year of follow-up with five or more of the seven scheduled visits. There were no patients who missed 50% of the visits. If a patient did not come to a scheduled visit, the therapist would call him or her, ask for the reason for not complying, and invite a visit as soon as possible. This invitation was nearly universally successful. Given the propensity for noncompliance in Russian Federation, the polyclinic rate of patient retention was very satisfying. The sustained commitment of the polyclinic leadership and practitioners was clearly demonstrable throughout the period of recruitment and follow-up. And it is a major building block on which to grow this program.
The second goal was reached also, although not all components of the clinical practice model are equally endorsed by outcomes. The core and continuing medical education of the therapists includes a strong emphasis on hypertension and cardiovascular disease and its prevention, averaging a quarter to a third of all CME hours. The attention to follow-up evinced by the therapists and their concerns that patients were not reaching target goals illuminate the level of understanding of the therapeutic goals. The record keeping and computer tracking of patients in this program endorse the data management potential within the polyclinic system. There were no equipment grants in this program. One area of concern that emerged was drug dosing. Although recognized as a worldwide problem that hypertensive patients are frequently underdosed both in quantity of prescribed medicine and in number of drugs prescribed, and was anticipated in this program, we found both aspects of this problem very evident. In the Russian Federation several factors may explain this. Patients are reticent to take many drugs in part because of costs and because of a strong belief in natural remedies. Therapists are fearful of side effects because of a fear of doing harm and a lack of experience and sophistication in polypharmacy. Costs of medicines are a major concern in the Russian Federation and no doubt play an important role in this setting. Most of these patients had elevated cholesterol and were prescribed both pharmacologic and dietary therapy. The lack of change in cholesterol levels is consistent with an unwillingness or inability to purchase statin drugs, which are expensive in the Russian Federation. The average monthly cost of a mid-range dose of a statin is $US 33 (L. Ziganshina, personal communication), a cost beyond the means of most Russians. If poor compliance is a clinical reality and costs a dominant concern, underdosing will occur.
The third goal, controlling BP and modifying risk factors for CVD and diabetes, was not met. Although the response of the concerted attempt to lower BP was significant, only 21% of patients with hypertension alone reached a target BP of 130/70 mm Hg and for those with both hypertension and diabetes, it was 28%. Considering the difficulty seen in Western Europe and the United States 9,10 in managing cardiovascular risk factors, these results are less dismaying. The EUROASPIRE report, 9 encompassing more than 3000 patients in nine countries, demonstrated that neither BP, smoking, nor weight goals were met, nor even approximated. Only cholesterol levels decreased, no doubt because of the impact of the well tolerated and available statin drugs. Nonetheless, because the primary goal is to reduce end-organ manifestation of CVD and diabetes in Tatarstan, the message is that much needs to be done.
Noncompliance is a major problem in the Russian Federation, probably more so than in the United States and Western Europe. 11 We regarded compliance as the patient's willingness to change diet, smoking, and exercise patterns, and to show up for appointments. Without reminders, participation in the follow-up phase of this study would have been very poor. We believe that the high compliance seen with medications was related to the high rate of attendance in the clinic after a time-consuming effort on the part of the polyclinic staff.
Another factor that helps to explain the lack of a robust response to intervention is the severity of illness in this group of patients. Most patients already showed end-organ dysfunction with left ventricular hypertrophy. Obesity and hyperlipidemia were nearly universal. And, of course, the baseline BP of approximately 170/100 mm Hg puts the group into an advanced class of hypertension by either ISH or the European Society of Hypertension guidelines.
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Observations and Recommendations
We have canvassed the literature using the database of the National Library of Medicine in both Russian and English. We could not find other studies of hypertension or risk factor management in the Russian polyclinic system. The epidemiology documents the severity of the problem, 5, 8, 13 thus making management of CVD an imperative next step.
The polyclinic management of chronic disease, especially CVD, can be done. We have shown that recruitment, retention, clinical management, and record keeping can be incorporated into the polyclinic system. Our group did offer special CME programs, encouragement from the academic community, support from the Ministry of Health, and outside consultants visiting as guest lecturers. These factors did help stimulate the interest of the staff. However, no additional funds were expended for this program and no new personnel added to the polyclinic staff. Should a widespread initiative in CVD risk factor management be inaugurated in Tatarstan, or the Russian Federation, enhanced attention from all interested agencies and CME programs will be part of it.
For community-wide amelioration of CVD risk factors, the public health effort must extend beyond the polyclinic. 13 In addition to an effective prevention program carried out in a primary care setting, community-wide education through various media will play a key role in raising the visibility of the problem and contributing to its solution. Engaging employers and schools to participate will be important. The public (ie, patients and their families) need to know that such efforts are important and that the health care system can and will help. The third component of a CVD prevention strategy is macroeconomic intervention. Examples of such interventions include tax and advertising policies regarding tobacco, agricultural subsidies that alter food consumption patterns in heart-healthy ways, and insertion of nutritional and exercise programs in primary and secondary school systems.
There are several issues that will certainly need to be addressed should a CVD prevention program be inaugurated. Male participation must improve. There are many potential reasons for the low male turnout, although we could not identify any specific reasons in this small study. Employment demands, an unwillingness to accept the diagnosis of an asymptomatic disease, alcohol abuse, 14 and a sense of hopelessness or loss of control over societal interactions 15 are all potential causes. In addition, management of an asymptomatic chronic illness for which daily medications and regular follow-up sessions are necessary requires a sense of control over one's own health. This sense, although difficult to define with absolute clarity, appears to be lacking in the Russian Federation. 14, 16 In conclusion, the burden of noncommunicable diseases, especially CVD, in the Russian Federation is enormous. During the working age years, 35 to 64 years, CVD mortality in the Russian Federation is nearly five times that of the United States. 13 Chronic disease management will need to become an indispensable part of a health care system if these extraordinary morbidity and mortality rates are to be curbed. 17 Our experience in a single polyclinic suggests that such programs would be endorsed and supported broadly.
